Markers of Inflammation and Cardiovascular Disease
Top Cited Papers
- 28 January 2003
- journal article
- guideline
- Published by Wolters Kluwer Health in Circulation
- Vol. 107 (3), 499-511
- https://doi.org/10.1161/01.cir.0000052939.59093.45
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- C-Reactive Protein — To Screen or Not to Screen?New England Journal of Medicine, 2002
- Risk of Myocardial Infarction and Angina in Patients With Severe Peripheral Vascular DiseaseCirculation, 2002
- Inflammation and coagulation factors in persons >65 years of age with symptoms of depression but without evidence of myocardial ischemia∗∗The opinions and assertions expressed herein are those of the authors and are not to be construed as reflecting the views of the USUHS or the US Department of Defense.The American Journal of Cardiology, 2002
- Long-term (≥8 years) outcome after palmaz-schatz stent implantationThe American Journal of Cardiology, 2001
- Fibrinogen and C-reactive protein on admission as markers of final infarct size after primary angioplasty for acute myocardial infarctionAtherosclerosis, 2001
- The association of c-reactive protein, serum amyloid a and fibrinogen with prevalent coronary heart disease — baseline findings of the PAIS projectAtherosclerosis, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Serum C-reactive protein and fibrinogen concentrations and self-reported angina pectoris and myocardial infarction: Findings from National Health and Nutrition Examination Survey IIIJournal of Clinical Epidemiology, 2000
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDYThe Lancet, 1986